Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2020 | Significance of p53 mutations in AML

David Sallman, MD, H. Lee Moffitt Cancer Center, Tampa, FL, outlines the significance of mutant p53 in acute myeloid leukemia (AML), and the clinical characteristics associated with this mutational profile, including 10-30% blast state, cytogenetic complexity, and severe pancytopenia. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).